Conference
3001 POSTER DISCUSSION Ultra-low-molecular-weight Heparin (ULMWH) Semuloparin for Prevention of Venous Thromboembolism (VTE) in Cancer Patients Receiving Chemotherapy: Consistent Beneficial Effect Across Cancer Stage and Location Subgroups
Authors
Agnelli G; George D; Fisher WD; Kakkar AK; Lassen MR; Mismetti P; Mouret P; Lawson F; Turpie AGG
Volume
47
Publisher
Elsevier
Publication Date
September 1, 2011
DOI
10.1016/s0959-8049(11)71074-7
Conference proceedings
European Journal of Cancer
ISSN
0959-8049